Literature DB >> 24050515

Haemophilus parahaemolyticus septic shock after aspiration pneumonia, France.

Anne-Sophie Le Floch, Nadim Cassir, Sami Hraiech, Christophe Guervilly, Laurent Papazian, Jean-Marc Rolain.   

Abstract

Entities:  

Keywords:  France; Haemophilus parahaemolyticus; MALDI-TOF; bacteria; emerging pathogen; matrix-assisted laser desorption ionization time-of-flight; pneumonia; respiratory infections

Mesh:

Substances:

Year:  2013        PMID: 24050515      PMCID: PMC3810756          DOI: 10.3201/eid1910.130608

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Members of the genus Haemophilus are commensal bacteria of the upper respiratory tract, and H. influenzae is the main pathogen in this genus that can cause a wide range of human infections (). The species most closely related to H. influenzae is H. haemolyticus, usually considered a commensal of the nasopharynx in humans; it can be pathogenic, although rarely (,). H. parahaemolyticus was distinguished from H. haemolyticus in 1953 when it was determined that H. parahaemolyticus required only factor V, but not factor X, for growth (). This species could be responsible for pharyngitis and, rarely, for subacute endocarditis (), but it has seldom been reported to cause invasive disease (). Invasive disease has been reported in a patient who had an empyema in the gallbladder () and in a patient who had a cryptogenic brain abscess (). We report a case of acute respiratory distress syndrome (ARDS) and septic shock caused by H. parahaemolyticus. A 50-year-old woman, who was receiving artificial ventilation, was transferred to the Hôpital Nord in Marseille, France, in November 2012. She was in a coma because she had taken an overdose of benzodiazepine and clomipramine in a suicide attempt. She had no relevant medical history except addiction to tobacco, chronic alcoholism, and depression. The patient’s family owned 3 cats and 1 dog but had no other pets. She had not traveled outside France. Notable findings on initial examination (before intubation) were shock (arterial blood pressure 80/50 mm Hg, despite adequate fluid resuscitation), tachycardia (pulse rate 110 beats/min), tachypnea (respiratory rate 34 respirations/min), low peripheral oxygen saturation (SpO2 80%), and a temperature of 39°C. On intensive care unit (ICU) admission, her partial pressure of arterial oxygen/fraction of inspired oxygen ratio was 101 under mechanical ventilation, with a positive end-expiratory pressure level of 10 cm H2O, consistent with ARDS. Chest examination revealed bilateral crackles on lower lung lobes, consistent with chest radiograph findings. Routine laboratory evaluation showed a hemoglobin level of 11.7 g/dL (reference 12.5–15.5 g/dL for women); leukocytosis, indicated by a leukocyte count of 23 cells × 109/L (reference 4–10 ×109/L); and elevated C-reactive protein level (298 mg/L [reference <5 mg/L]). On the second day, a bronchoalveolar lavage (BAL) specimen (obtained before initiation of antimicrobial drug therapy) was positive for H. parahaemolyticus (107 CFU/mL) on a chocolate polyvitex agar plate, and the strain showed susceptibility to ampicillin/clavulanate, ceftriaxone, rifampin, gentamicin, and ciprofloxacin. The bacterium was hemolytic and required factor V, but not factor X, for growth. The bacterium was identified in the laboratory by matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry with the Bruker Biotyper software database (Bruker Daltonics, Bremen, Germany), with a good score (>2.0) (). The identification was confirmed by PCR amplification and sequencing of the 16S rRNA gene (size of sequence was 1,387 bp, and it had 99.6% homology with sequence AJ295746 in GenBank). Blood culture results were negative for both bacterial species. The final diagnosis was septic shock associated with ARDS, due to aspiration pneumonia. In the ICU, the patient received ampicillin/clavulanate and gentamicin, along with vasopressor therapy and crystalloid fluid resuscitation. Her response was dramatic, and her condition improved rapidly. When she was stabilized and able to take oral drugs, she was given ampicillin/clavulanate, 1 g 3× daily for 7 days. On day 9, she was discharged from the ICU in stable condition. One month after discharge, she attended a follow-up visit at the pulmonary outpatient department and had made a full recovery. This study shows the isolation in pure culture of H. parahaemolyticus from the BAL specimen of a patient with septic shock with ARDS. The isolate was unambiguously identified by MALDI-TOF () and confirmed by 16S rRNA sequencing. Correct identification of bacteria of the genus Haemophilus at the species level, including H. parahaemolyticus, by MALDI-TOF, has also been reported in 2 recent works (,). Isolation of this bacterium in pure culture from the BAL specimen was eventually associated with the disease of the patient (including a coma complicated with aspiration pneumonia and bilateral pulmonary consolidations), and the patient rapidly improved after receiving antimicrobial drug treatment. These findings suggest that H. parahaemolyticus was the causative agent of the patient’s disease. Although this bacterium has been rarely reported as a cause of human infections, it should be considered as an opportunistic pathogen, especially in patients who have aspiration pneumonia, because it is likely a commensal of the upper respiratory tract. Among 31 H. parahaemolyticus isolates from human specimens reported by Nørskov-Lauritsen et al., 75% of the isolates were recovered as commensals in the pharynx and throat and from sputum (). This bacterium was likely overlooked in the past because phenotypic identification was not sufficiently accurate to distinguish it from other Haemophilus spp. Thus, H. parahaemolyticus has a pathogenic potential for causing invasive and severe diseases in humans that should be further investigated.
  10 in total

1.  A classification of the hemolytic bacteria of the genus Haemophilus: Haemophilus haemolyticus Bergey et al. and Haemophilus parahaemolyticus nov spec.

Authors:  M PITTMAN
Journal:  J Bacteriol       Date:  1953-06       Impact factor: 3.490

2.  An invasive Haemophilus haemolyticus isolate.

Authors:  Daniel J Morton; Randy J Hempel; Paul W Whitby; Thomas W Seale; Terrence L Stull
Journal:  J Clin Microbiol       Date:  2012-02-01       Impact factor: 5.948

3.  Isolation of Haemophilus parahaemolyticus in a patient with cryptogenic brain abscess.

Authors:  C C Chen; S J Wang; J L Fuh
Journal:  Scand J Infect Dis       Date:  2001

4.  Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.

Authors:  Piseth Seng; Michel Drancourt; Frédérique Gouriet; Bernard La Scola; Pierre-Edouard Fournier; Jean Marc Rolain; Didier Raoult
Journal:  Clin Infect Dis       Date:  2009-08-15       Impact factor: 9.079

5.  A taxonomic study of the genus Haemophilus, with the proposal of a new species.

Authors:  M Kilian
Journal:  J Gen Microbiol       Date:  1976-03

6.  Identification of haemolytic Haemophilus species isolated from human clinical specimens and description of Haemophilus sputorum sp. nov.

Authors:  Niels Nørskov-Lauritsen; Brita Bruun; Camilla Andersen; Mogens Kilian
Journal:  Int J Med Microbiol       Date:  2012-02-13       Impact factor: 3.473

Review 7.  Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates.

Authors:  H Peltola
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

8.  Empyema of the gallbladder due to Haemophilus parahaemolyticus, with a brief review of its role as a pathogen.

Authors:  M Parsons; I Faris
Journal:  J Clin Pathol       Date:  1973-08       Impact factor: 3.411

9.  Haemophilus haemolyticus isolates causing clinical disease.

Authors:  Raydel Anderson; Xin Wang; Elizabeth C Briere; Lee S Katz; Amanda C Cohn; Thomas A Clark; Nancy E Messonnier; Leonard W Mayer
Journal:  J Clin Microbiol       Date:  2012-05-09       Impact factor: 5.948

10.  MALDI-TOF MS distinctly differentiates nontypable Haemophilus influenzae from Haemophilus haemolyticus.

Authors:  Bingqing Zhu; Di Xiao; Huifang Zhang; Yongchan Zhang; Yuan Gao; Li Xu; Jing Lv; Yingtong Wang; Jianzhong Zhang; Zhujun Shao
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

  10 in total
  4 in total

1.  Haemophilus influenzae: using comparative genomics to accurately identify a highly recombinogenic human pathogen.

Authors:  Erin P Price; Derek S Sarovich; Elizabeth Nosworthy; Jemima Beissbarth; Robyn L Marsh; Janessa Pickering; Lea-Ann S Kirkham; Anthony D Keil; Anne B Chang; Heidi C Smith-Vaughan
Journal:  BMC Genomics       Date:  2015-08-27       Impact factor: 3.969

2.  PathogenTrack and Yeskit: tools for identifying intracellular pathogens from single-cell RNA-sequencing datasets as illustrated by application to COVID-19.

Authors:  Wei Zhang; Xiaoguang Xu; Ziyu Fu; Jian Chen; Saijuan Chen; Yun Tan
Journal:  Front Med       Date:  2022-02-22       Impact factor: 9.927

3.  Insights into the Profile of the Human Expiratory Microbiota and Its Associations with Indoor Microbiotas.

Authors:  Yin Zhang; Fangxia Shen; Yi Yang; Mutong Niu; Da Chen; Longfei Chen; Shengqi Wang; Yunhao Zheng; Ye Sun; Feng Zhou; Hua Qian; Yan Wu; Tianle Zhu
Journal:  Environ Sci Technol       Date:  2022-05-05       Impact factor: 11.357

4.  Dysbiosis in the Salivary Microbiome Associated with IgA Nephropathy-‍A‍ ‍Japanese Cohort Study.

Authors:  Anushka Khasnobish; Lena Takayasu; Ken-Ichi Watanabe; Tien Thi Thuy Nguyen; Kensuke Arakawa; Osamu Hotta; Kensuke Joh; Akiyo Nakano; Shuhei Hosomi; Masahira Hattori; Wataru Suda; Hidetoshi Morita
Journal:  Microbes Environ       Date:  2021       Impact factor: 2.912

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.